Prelude Capital Management’s UnitedHealth UNH Stock Holding History

Prelude Capital Management’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$263K	–	1537
2023 Q4	$263K	Hold	500	–	–	0.02%	801
2023 Q3	$252K	Buy	+500	New	+$246K	0.02%	771
2023 Q1	–	Sell	-1,000	Closed	-$530K	–	1478
2022 Q4	$530K	Buy	+1,000	New	+$530K	0.03%	545
2022 Q3	–	Sell	-1,000	Closed	-$514K	–	1925
2022 Q2	$514K	Sell	1,000 -1,500	-60%	-$753K	0.01%	796
2022 Q1	$1.27M	Hold	2,500	–	–	0.04%	499
2021 Q4	$1.25M	Buy	+2,500	New	+$1.13M	0.03%	505
2019 Q4	–	Sell	-100	Closed	-$22K	–	2265
2019 Q3	$22K	Buy	+100	New	+$24.1K	﹤0.01%	1373

Other funds holding UNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prelude Capital Management's UNH Position: Q1 2026 in Review

Prelude Capital Management sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 2,711 shares — an estimated $895K sold.

Prelude Capital Management first reported a position in UNH in Q2 2013 and held it in 39 quarters. The position peaked at $4.52M in Q3 2016. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

Prelude Capital Management reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 2,711 UnitedHealth shares in Q1 2026, an estimated $895K.
Prelude Capital Management first reported a position in UnitedHealth in Q2 2013 and held it in 39 quarters.
Prelude Capital Management's UnitedHealth position peaked at $4.52M in Q3 2016.
3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.